Related Experiment Video

Updated: Aug 14, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Heart failure mortality trend in Salvador, Bahia, Brazil]

Adriana Lopes Latado1, Luiz Carlos Santana Passos, Rodrigo Guedes

  • 1Universidade Federal da Bahia, Secretaria de Saúde da Bahia, Salvador, BA. adrianalatado@cardiol.br

Arquivos Brasileiros De Cardiologia
|December 17, 2005
PubMed

Insights

Heart failure (HF) mortality in Salvador, Brazil, significantly decreased by 34.4% between 1979 and 1995. Rates stabilized after 1992, indicating a positive public health trend for cardiovascular disease.

Area of Science:

  • Cardiovascular Epidemiology
  • Public Health Research
  • Morbidity and Mortality Studies

Context:

  • Heart failure (HF) represents a significant global health burden.
  • Understanding regional mortality trends is crucial for targeted interventions.
  • This study examines HF mortality in Salvador, Bahia, Brazil, over a 17-year period.

Purpose:

  • To analyze the mortality trends associated with heart failure (HF) in Salvador, Bahia.
  • To quantify changes in HF death rates from 1979 to 1995.
  • To identify demographic patterns in HF mortality.

Summary:

  • Mortality rates due to heart failure (HF) demonstrated a progressive decline from 1979 to 1992, with a subsequent stabilization until 1995.
  • Overall gross mortality rate decreased by 34.4%, with similar reductions observed for both male and female populations.
  • Age-adjusted rates indicated even greater relative reductions, highlighting a positive trend across various age groups.

Impact:

  • The findings suggest successful public health strategies or improved clinical management of heart failure in the region.
  • This epidemiological data can inform future healthcare planning and resource allocation for cardiovascular diseases.
  • The study provides valuable insights into long-term trends of heart failure mortality in a major Brazilian metropolitan area.
Abstract

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...